Skip to main content
. 2017 Jan 25;7:10. doi: 10.3389/fonc.2017.00010

Table 1.

Oxymetric studies linking hypoxia and radiation therapy outcome.

Oxymetric technique Animal studies Reference Clinical studies Reference Cross-validation with quantitative oxymetric methods? Reference
Eppendorf electrodes C3H mammary tumors: significant difference in local tumor control between the fraction of hypoxic values (<2.5 mmHg) and less hypoxic tumors (36) Prostate cancer study (n = 57): 8-year survival is 78% for moderately hypoxic tumors and 46% for severe hypoxic tumors (16) n.a.

Head and neck cancer study (n = 35): 2-year locoregional control is two times lower for hypoxic tumors (i.e., with 15% of readings <2.5 mmHg) (15)

PET 18F-MISO FaDu hSCC xenografts: prognostic value of pretreatment 18F-MISO hypoxic volume; SUVmax was not associated with local control (25) 5 head and neck studies (n = 45; 73; 12; 17; 15) (21, 24, 26, 27, 29) Mixed results (23)
  • 4 studies reported correlation between 18F-MISO hypoxia and outcome

  • 1 study reported a lack of correlation

Lack of correlation with Eppendorf measurements in head and neck tumors

PET 18F-FAZA Rhabdomyosarcoma: lower uptake linked to better local tumor control at 90 days post-irradiation (36) Head and neck cancer study: DAHANCA trial (n = 40), high tumor uptake is correlated to lower disease-free survival (38) Positive results (38)
Validated with EPR oximetry in the preclinical setting (rat rhabdomyosarcomas)

9L glioma and rhabdomyosarcoma: significant correlation between 18F-FAZA T/B and tumor growth delay (37)

PET 18F-FETNIM 1 head and neck cancer study (n = 21) (21) NO (but compared with other nitroimidazoles) (44, 45)
2 lung cancer studies (n = 26; 32)
  • Comparison with F-MISO: positive response under hyperoxic breathing challenge in C3H murine tumors

  • Comparison with FAZA: positive correlation in murine mammary tumors

1 cervical cancer study (n = 16)
1 esophageal cancer study (n = 28)
High fractional hypoxic volumes, uptake, or baseline SUVmax correlated with PFS, OS, or clinical response

PET 60CU-ATSM Canine sinonasal tumors: lack of correlation between Cu-ATSM uptake and outcome (51) 3 cervical cancer studies (n = 14; 15; 38) (21, 4850) Mixed results (40, 5763)
2 head and neck cancer studies (n = 15; 11)
  • Comparison with F-MISO, EF5, or pimonidazole: no link with hypoxia in different tumor models or in response to hyperoxic challenges

  • Comparison with Eppendorf electrodes: correlation with hypoxia in FaDu tumors but not in HT29 tumors

3 lung cancer studies (n = 19; 22; 7) Potential link with tumor redox status
1 rectal cancer study (n = 19)
  • Tumor uptake is inversely related to PFS or disease specific free survival

  • Hypoxic tumor volume and hypoxic burden (=HTV × SUVmean) related to PFS


Dynamic contrast-enhanced magnetic resonance imaging Melanoma xenografts: low ktrans is correlated with increased radioresistance (78) Cervical cancer study: ktrans and ABrix parameters correlated with poor outcome (80) Mixed results (82)
  • Comparison with Eppendorf electrodes: correlation between max DCE signal enhancement and median pO2 in cervical cancer patients


Cervical cancer xenografts: basal ktrans correlated to the outcome of RT; skewness (heterogeneity) in ktrans distribution correlated with poorer outcome (79)
  • Comparison with pimonidazole

  • Correlation between “poor perfusion” parameters and hypoxia (pimonidazole staining) in head and neck cancer patients

  • Lack of correlation in glioma mice xenografts and glioma patients

(83, 84)

Mouse fibrosarcoma: none of the tested DCE parameters (ktrans, vp, Kep, % of perfused voxels) were related to RT outcome (69)

R2*T2* G3H prolactinomas (rats) (100) Cervical cancer study: basal R2* was predictive for RT response 90 Mixed results (9698)
RIF-1 fibrosarcomas (mice)
  • Lack of quantitative relationship between fluorescence quenching fiber optic probes pO2 values and ΔT2* values

  • Correlation between pimonidazole and high R2* in prostate cancer

  • Inverse correlation between pimonidazole and R2* in mammary tumors

ΔR2* was predictive for a transient reduction in tumor size; low baseline R2* was linked to a small reduction in tumor size

R1T1 of water protons Dunning R3327-AT1 rat prostate (92) Mixed results
A large increase in R1 response to hyperoxic challenge was linked to a longer tumor growth delay after radiation therapy No study addressing potential correlations between R1T1 and quantitative pO2 measurements

R1T1 of lipid protons 9L glioma (101) Mixed results (101, 123)
Water and lipids T1 are less predictive of RT outcome than R2* in this model
  • Comparison with EPR oximetry

  • Positive correlation in mammary tumors

  • Lack of correlation in rat rhabdomyosarcoma and 9L glioma


Combined R1 and R2* MRI Dunning rat prostate tumors (121)
Useful factors to predict tumor response to hypofractionation

EPR oximetry C6 and 9L glioma (151)
pO2 assessed after a first course of RT was a prognostic indicator of differential response to RT between the two glioma models

TLT and FSaII syngeneic tumors (69, 76, 130, 132, 136146, 148)
pO2 assessed during/after administration of treatments able to alleviate tumor oxygenation was predictive of the outcome of RT when administered during this window of reoxygenation